Abstract
Purpose
Adults with diabetes are at increased risk of being diagnosed with and dying from colorectal cancer, but it is unclear whether colorectal cancer screening (CRCS) use is lower in this population. Using the 2008 and 2010 National Health Interview Survey data, we examined whether guideline-concordant CRCS is lower among men and women with self-reported diabetes.
Methods
We calculated the weighted percentage of guideline-concordant CRCS and unadjusted and adjusted prevalence ratios (PR) comparing adults aged 51–75 years with diabetes (n = 6,514) to those without (n = 8,371). We also examined effect modification by age (51–64 and 65–75), race/ethnicity, and number of medical office visits (0–3, ≥4).
Results
The unadjusted prevalence of CRCS among men with diabetes was significantly higher than men without (63.3 vs. 58.0 %; PR = 1.09 95 % CI 1.03–1.16). In adjusted models, this relationship was evident among older [adjusted PR (aPR) = 1.13 95 % CI 1.06–1.21] but not younger men (aPR = 0.99 95 % CI 0.91–1.08; p for interaction term ≤0.01). There was no significant association between diabetes and CRCS among women overall (56.6 vs. 57.9 %; PR = 0.98 95 % CI 0.92–1.04) or by age group. Race/ethnicity and the number of medical visits did not significantly modify the association between diabetes and CRCS for men or women.
Conclusions
Men and women with self-reported diabetes were not less likely to be up to date with CRCS than those without diabetes. Older men with diabetes were more likely to be up to date with CRCS than those without diabetes.
Similar content being viewed by others
References
American Cancer Society (2011) Colorectal cancer facts and figures 2011–2013. American Cancer Society, Atlanta
Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN et al (2010) Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116(3):544–573
US Preventive Services Task Force (2008) Clinical guidelines: screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 149(9):627–637
Centers for Disease Control and Prevention (2012) Cancer screening—United States, 2010. MMWR Morb Mortal Wkly Rep 61(3):41–45
Larsson SC, Orsini N, Wolk A (2005) Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97(22):1679–1687
Yuhara H, Steinmaus C, Cohen SE, Corley DA, Tei Y, Buffler PA (2011) Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol 106(11):1911–1921
Onitilo AA, Engel JM, Glurich I, Stankowski RV, Williams GM, Doi SA (2012) Diabetes and cancer I: risk, survival, and implications for screening. Cancer Causes Control 23(6):967–981
Stein KB, Snyder CF, Barone BB, Yeh HC, Peairs KS, Derr RL et al (2010) Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis. Dig Dis Sci 55(7):1839–1851
Lehnert T, Heider D, Leicht H, Heinrich S, Corrieri S, Luppa M et al (2011) Review: health care utilization and costs of elderly persons with multiple chronic conditions. Med Care Res Rev 68(4):387–420
Natarajan S, Nietert PJ (2004) Hypertension, diabetes, hypercholesterolemia, and their combinations increased health care utilization and decreased health status. J Clin Epidemiol 57(9):954–961
Fleming ST, Love MM, Bennett K (2011) Diabetes and cancer screening rates among Appalachian and non-Appalachian residents of Kentucky. J Am Board Fam Med 24(6):682–692
McBean AM, Yu X (2007) The underuse of screening services among elderly women with diabetes. Diabetes Care 30(6):1466–1472
Bell RA, Shelton BJ, Paskett ED (2001) Colorectal cancer screening in North Carolina: associations with diabetes mellitus and demographic and health characteristics. Prev Med 32(2):163–167
Owens MD, Beckles GL, Ho KK, Gorrell P, Brady J, Kaftarian JS (2008) Women with diagnosed diabetes across the life stages: underuse of recommended preventive care services. J Women’s Health 17(9):1415–1423
Zhao G, Ford ES, Ahluwalia IB, Li C, Mokdad AH (2009) Prevalence and trends of receipt of cancer screenings among US women with diagnosed diabetes. J Gen Intern Med 24(2):270–275
Meissner HI, Breen N, Klabunde CN, Vernon SW (2006) Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 15(2):389–394
Correa-de-Araujo R, McDermott K, Moy E (2006) Gender differences across racial and ethnic groups in the quality of care for diabetes. Women’s Health Issues 16(2):56–65
Nau DP, Mallya U (2005) Sex disparity in the management of dyslipidemia among patients with type 2 diabetes mellitus in a managed care organization. Am J Manag Care 11(2):69–73
Wexler DJ, Grant RW, Meigs JB, Nathan DM, Cagliero E (2005) Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 28(3):514–520
2010 NHIS Survey Description: Centers for Disease Control and Prevention, National Center for Health Statistics (2011). ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHIS/2010/srvydesr.pdf. Accessed 4 April 2012
National Center for Health Statistics (2013) Health, United States, 2012: with special feature on emergency care. Hyattsville, Maryland
Baier M, Calonge N, Cutter G, McClatchey M, Schoentgen S, Hines S et al (2000) Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiol Biomarkers Prev 9(2):229–232
Hall HI, Van Den Eeden SK, Tolsma DD, Rardin K, Thompson T, Hughes Sinclair A et al (2004) Testing for prostate and colorectal cancer: comparison of self-report and medical record audit. Prev Med 39(1):27–35
Bieler GS, Brown GG, Williams RL, Brogan DJ (2010) Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data. Am J Epidemiol 171(5):618–623
Brawarsky P, Brooks DR, Mucci LA, Wood PA (2004) Effect of physician recommendation and patient adherence on rates of colorectal cancer testing. Cancer Detect Prev 28(4):260–268
Friedemann-Sanchez G, Griffin JM, Partin MR (2007) Gender differences in colorectal cancer screening barriers and information needs. Health Expect 10(2):148–160
McQueen A, Vernon SW, Meissner HI, Klabunde CN, Rakowski W (2006) Are there gender differences in colorectal cancer test use prevalence and correlates? Cancer Epidemiol Biomarkers Prev 15(4):782–791
Burgess JB, van Ryn M, Grill J, Noorbaloochi S, Griffin JM, Ricards J, Vernon SW, Fisher DA, Partin MR (2010) Presence and correlates of racial disparities in adherence to colorectal cancer screening guidelines. J Gen Intern Med 26(3):251–258
Wilkinson JE, Culpepper L (2011) Associations between colorectal cancer screening and glycemic control in people with diabetes, Boston, Massachusetts, 2005–2010. Prev Chron Dis 8(4):A82
Schenck AP, Klabunde CN, Warren JL, Jackson E, Peacock S, Lapin P (2005) Physician visits and colorectal cancer testing among Medicare enrollees in North Carolina and South Carolina. Prev Chronic Dis 8(5):A112
Rauscher GH, Johnson TP, Cho YI, Walk JA (2008) Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev 17(4):748–757
Healthy People 2020: US Department of Health and Human Services, Office of Disease Prevention and Health Promotion. http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=5. Accessed 6 Sept 2012
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miller, E.A., Tarasenko, Y.N., Parker, J.D. et al. Diabetes and colorectal cancer screening among men and women in the USA: National Health Interview Survey: 2008, 2010. Cancer Causes Control 25, 553–560 (2014). https://doi.org/10.1007/s10552-014-0360-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-014-0360-z